Peak Processing Limited (ASX: PKP)
Health Care · Pharmaceuticals · AU
AU$0.02
+6.25% today · -15.0% 1Y
Peak Processing Limited (ASX: PKP) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $15.83M and employs 0 people.
Over the last twelve months the share price has lost 15.0%, trading between 0.01 and 0.02.
Tweenvest scores Peak Processing Limited across four factors: quality 25/100, value 51/100, growth 15/100. Its strongest factor is value.
PKP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $15.83M
- Revenue (TTM)
- $8.60M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 1.29
- 52-week high
- AU$0.02
- 52-week low
- AU$0.01
- Avg volume (3M)
- —
- Shares outstanding
- 1.34B
- Employees
- 0
- Next earnings
- —
About Peak Processing Limited
Based in Melbourne, Australia, and founded in 2016, Peak Processing Limited, alongside its subsidiaries, is engaged in the manufacturing, distribution, and sale of recreational cannabis products throughout Canada and the United States. Its extensive product line, available through retail outlets, features items such as beverages, hydrocarbon extracts, various oils, vapes, topicals, powders, infused flowers, and edibles. Furthermore, the company provides a suite of services, including market analysis, product development, production, commercialization strategies, logistical distribution, and product refurbishment. Notably, the firm was previously known as Althea Group Holdings Limited and is slated to officially change its name to Peak Processing Limited in November 2025.
- ISIN
- AU0000442287
- Founded
- 2016
- Listed since
- Sep 20, 2018
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| MFC Co., Ltd.KOSE: A432980 | $16.33M | ₩2,555.00 | -2.11% |
| Rocket One Inc.NasdaqCM: RKTO | $16.17M | $0.60 | -8.36% |
| Kiora Pharmaceuticals, Inc.NasdaqCM: KPRX | $16.16M | $2.52 | -0.79% |
| Devonian Health Group Inc.TSXV: GSD | $16.08M | CA$8.25 | +3.13% |
| Otsuka Pakistan LimitedKASE: OTSU | $15.72M | PKRs359.78 | +0.79% |
| Bal Pharma LimitedBSE: 524824 | $15.32M | Rs93.15 | -11.79% |
| Auro Laboratories LimitedBSE: 530233 | $15.24M | Rs236.60 | -2.95% |
| PeterLabs Holdings BerhadKLSE: PLABS | $15.16M | RM0.23 | +2.27% |
Figures last refreshed Oct 11, 2026.